Regulators discuss "critical issues" in dementia R&D at Rome meeting
This article was originally published in SRA
Regulators and academics are meeting in Rome to discuss ways of improving the diagnosis and treatment of dementia, with the focus on aspects such as clinical trial design, endpoints and benefit-risk balance, and the possibility of expedited drug approval procedures.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
A number of countries are resorting to extreme measures such as export bans to preserve stocks of medicines for the COVID-19 pandemic. Belgium is among the latest to impose an export prohibition, but might it fall foul of the EU’s export regulations?
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.